ZENPEP (Physicians Total Care, Inc.)


Welcome to the PulseAid listing for the ZENPEP drug offered from Physicians Total Care, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Physicians Total Care, Inc.
NON-PROPRIETARY NAME: pancrelipase
SUBSTANCE NAME: PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE; PANCRELIPASE AMYLASE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: CAPSULE, DELAYED RELEASE
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2014-09-12
END MARKETING DATE: 0000-00-00


ZENPEP HUMAN PRESCRIPTION DRUG Details:

Item DescriptionZENPEP from Physicians Total Care, Inc.
LABELER NAME: Physicians Total Care, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 10000; 34000; 55000([USP’U]/1; [USP’U]/1; [USP’U]/1)
START MARKETING DATE: 2014-09-12
END MARKETING DATE: 0000-00-00
PRODUCT ID: 54868-6435_eaa6c757-097c-4e9a-84b4-e4dfc403e18a
PRODUCT NDC: 54868-6435
APPLICATION NUMBER: NDA022210

Other PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE; PANCRELIPASE AMYLASE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AbbVie Inc.Creon
Allergan, Inc.Zenpep
Aptalis Pharma US, IncULTRESA
Aptalis Pharma US, Inc.ZENPEP
Atlantic Biologicals CorpsCreon
Physicians Total Care, Inc.ZENPEP
X-GEN Pharmaceuticals, Inc.PANCRELIPASE